Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
Google Scholar
Nicholson WK, Silverstein M, Wong JB, Barry MJ, Chelmow D, Coker TR, Davis EM, Jaén CR, Krousel-Wood M, Lee S, et al. Screening for breast cancer: US preventive services task force recommendation statement. JAMA. 2024;331(22):1918–30.
Google Scholar
Thakur C, Qiu Y, Pawar A, Chen F. Epigenetic regulation of breast cancer metastasis. Cancer Metastasis Rev. 2024;43(2):597–619.
Google Scholar
Roulot A, Héquet D, Guinebretière J-M, Vincent-Salomon A, Lerebours F, Dubot C, Rouzier R. Tumoral heterogeneity of breast cancer. Ann Biol Clin (Paris). 2016;74(6):653–60.
Google Scholar
Tuasha N, Petros B. Heterogeneity of Tumors in Breast Cancer: Implications and Prospects for Prognosis and Therapeutics. Scientifica (Cairo) 2020, 2020:4736091.
Sotiriou C, Neo S-Y, McShane LM, Korn EL, Long PM, Jazaeri A, Martiat P, Fox SB, Harris AL, Liu ET. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A. 2003;100(18):10393–8.
Google Scholar
Goldner M, Pandolfi N, Maciel D, Lima J, Sanches S, Pondé N. Combined endocrine and targeted therapy in luminal breast cancer. Expert Rev Anticancer Ther. 2021;21(11):1237–51.
Google Scholar
Voduc KD, Cheang MCU, Tyldesley S, Gelmon K, Nielsen TO, Kennecke H. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol. 2010;28(10):1684–91.
Google Scholar
Su Y, Zheng Y, Zheng W, Gu K, Chen Z, Li G, Cai Q, Lu W, Shu XO. Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study. BMC Cancer. 2011;11:292.
Google Scholar
Yin L, Duan J-J, Bian X-W, Yu S-C. Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res. 2020;22(1):61.
Google Scholar
Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanisławek A. Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review. Cancers (Basel) 2021, 13(17).
Gianni L, Pienkowski T, Im Y-H, Tseng L-M, Liu M-C, Lluch A, Starosławska E, de la Haba-Rodriguez J, Im S-A, Pedrini JL, et al. 5-year analysis of neoadjuvant Pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial. Lancet Oncol. 2016;17(6):791–800.
Google Scholar
Bear HD, Anderson S, Smith RE, Geyer CE, Mamounas EP, Fisher B, Brown AM, Robidoux A, Margolese R, Kahlenberg MS, et al. Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:national surgical adjuvant breast and bowel project protocol B-27. J Clin Oncol. 2006;24(13):2019–27.
Google Scholar
Gerlinger M, Rowan AJ, Horswell S, Math M, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366(10):883–92.
Google Scholar
Rossi C, Fraticelli S, Fanizza M, Ferrari A, Ferraris E, Messina A, Della Valle A, Anghelone CAP, Lasagna A, Rizzo G, et al. Concordance of immunohistochemistry for predictive and prognostic factors in breast cancer between biopsy and surgical excision: a single-centre experience and review of the literature. Breast Cancer Res Treat. 2023;198(3):573–82.
Google Scholar
Meattini I, Bicchierai G, Saieva C, De Benedetto D, Desideri I, Becherini C, Abdulcadir D, Vanzi E, Boeri C, Gabbrielli S, et al. Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: Single-institution experience and review of published literature. Eur J Surg Oncol. 2017;43(4):642–8.
Google Scholar
Wang L. Early Diagnosis of Breast Cancer. Sensors (Basel) 2017, 17(7).
Pinsky RW, Helvie MA. Mammographic breast density: effect on imaging and breast cancer risk. J Natl Compr Canc Netw 2010, 8(10).
Kuhl CK, Keulers A, Strobel K, Schneider H, Gaisa N, Schrading S. Not all false positive diagnoses are equal: on the prognostic implications of false-positive diagnoses made in breast MRI versus in mammography / digital tomosynthesis screening. Breast Cancer Res. 2018;20(1):13.
Google Scholar
Chudgar AV, Conant EF, Weinstein SP, Keller BM, Synnestvedt M, Yamartino P, McDonald ES. Assessment of disease extent on contrast-enhanced MRI in breast cancer detected at digital breast tomosynthesis versus digital mammography alone. Clin Radiol. 2017;72(7):573–9.
Google Scholar
Tagliafico AS, Calabrese M, Mariscotti G, Durando M, Tosto S, Monetti F, Airaldi S, Bignotti B, Nori J, Bagni A, et al. Adjunct screening with tomosynthesis or ultrasound in women with Mammography-Negative dense breasts: interim report of a prospective comparative trial. J Clin Oncol. 2016;34(16):1882–8.
Google Scholar
Guo R, Lu G, Qin B, Fei B. Ultrasound imaging technologies for breast cancer detection and management: A review. Ultrasound Med Biol. 2018;44(1):37–70.
Google Scholar
Uematsu T. Ultrasonographic findings of missed breast cancer: pitfalls and pearls. Breast Cancer. 2014;21(1):10–9.
Google Scholar
Eom H-J, Cha JH, Choi WJ, Chae EY, Shin HJ, Kim HH. Predictive clinicopathologic and dynamic Contrast-Enhanced MRI findings for tumor response to neoadjuvant chemotherapy in Triple-Negative breast cancer. AJR Am J Roentgenol. 2017;208(6):W225–30.
Google Scholar
Becker A, Masthoff M, Claussen J, Ford SJ, Roll W, Burg M, Barth PJ, Heindel W, Schäfers M, Eisenblätter M, et al. Multispectral optoacoustic tomography of the human breast: characterisation of healthy tissue and malignant lesions using a hybrid ultrasound-optoacoustic approach. Eur Radiol. 2018;28(2):602–9.
Google Scholar
Oraevsky AA, Clingman B, Zalev J, Stavros AT, Yang WT, Parikh JR. Clinical optoacoustic imaging combined with ultrasound for coregistered functional and anatomical mapping of breast tumors. Photoacoustics. 2018;12:30–45.
Google Scholar
Kim J, Park B, Ha J, Steinberg I, Hooper SM, Jeong C, Park E-Y, Choi W, Liang T, Bae JS, et al. Multiparametric photoacoustic analysis of human thyroid cancers in vivo. Cancer Res. 2021;81(18):4849–60.
Google Scholar
Huang Z, Tian H, Luo H, Yang K, Chen J, Li G, Ding Z, Luo Y, Tang S, Xu J et al. Assessment of oxygen saturation in breast lesions using photoacoustic imaging: correlation with benign and malignant disease. Clin Breast Cancer 2024, 24(4).
Huang Z, Mo S, Wu H, Kong Y, Luo H, Li G, Zheng J, Tian H, Tang S, Chen Z, et al. Optimizing breast cancer diagnosis with photoacoustic imaging: an analysis of intratumoral and peritumoral radiomics. Photoacoustics. 2024;38:100606.
Google Scholar
Peng X, Xu Z, Dentinger A, Kewalramani S, Jo J, Xu G, Chamberland D, Abdulaziz N, Gandikota G, Mills D, et al. Longitudinal volumetric assessment of inflammatory arthritis via photoacoustic imaging and doppler ultrasound imaging. Photoacoustics. 2023;31:100514.
Google Scholar
Niederhauser JJ, Jaeger M, Lemor R, Weber P, Frenz M. Combined ultrasound and optoacoustic system for real-time high-contrast vascular imaging in vivo. IEEE Trans Med Imaging. 2005;24(4):436–40.
Google Scholar
Liu S, Zhang R, Han T, Pan Y, Zhang G, Long X, Zhao C, Wang M, Li X, Yang F, et al. Validation of photoacoustic/ultrasound dual imaging in evaluating blood oxygen saturation. Biomed Opt Express. 2022;13(10):5551–70.
Google Scholar
Pugh CW, Gleadle J, Maxwell PH. Hypoxia and oxidative stress in breast cancer. Hypoxia signalling pathways. Breast Cancer Res. 2001;3(5):313–7.
Google Scholar
Sivasubramanian M, Lo L-W. Assessment of Nanoparticle-Mediated tumor oxygen modulation by photoacoustic imaging. Biosens (Basel) 2022, 12(5).
Li G, Huang Z, Tian H, Wu H, Zheng J, Wang M, Mo S, Chen Z, Xu J, Dong F. Deep learning combined with attention mechanisms to assist radiologists in enhancing breast cancer diagnosis: a study on photoacoustic imaging. Biomed Opt Express. 2024;15(8):4689–704.
Google Scholar
Gao L, Li J, Gu Y, Ma L, Xu W, Tao X, Wang R, Zhang R, Zhang Y, Wang H, et al. Breast ultrasound in Chinese hospitals: A cross-sectional study of the current status and influencing factors of BI-RADS utilization and diagnostic accuracy. Lancet Reg Health West Pac. 2022;29:100576.
Google Scholar
Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RGPM, Granton P, Zegers CML, Gillies R, Boellard R, Dekker A, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48(4):441–6.
Google Scholar
Li W, Yu K, Feng C, Zhao D. Molecular subtypes recognition of breast cancer in dynamic Contrast-Enhanced breast magnetic resonance imaging phenotypes from radiomics data. Comput Math Methods Med. 2019;2019:6978650.
Google Scholar
Liu J, Bian H, Zhang Y, Gao Y, Yin G, Wang Z, Li X, Ma W, Xu W. Molecular subtype classification of breast cancer using established radiomic signature models based on 18F-FDG PET/CT images. Front Biosci (Landmark Ed). 2021;26(9):475–84.
Google Scholar
Gong X, Li Q, Gu L, Chen C, Liu X, Zhang X, Wang B, Sun C, Yang D, Li L, et al. Conventional ultrasound and contrast-enhanced ultrasound radiomics in breast cancer and molecular subtype diagnosis. Front Oncol. 2023;13:1158736.
Google Scholar
Ma W, Zhao Y, Ji Y, Guo X, Jian X, Liu P, Wu S. Breast cancer molecular subtype prediction by mammographic radiomic features. Acad Radiol. 2019;26(2):196–201.
Google Scholar
Hameed Z, Garcia-Zapirain B, Aguirre JJ, Isaza-Ruget MA. Multiclass classification of breast cancer histopathology images using multilevel features of deep convolutional neural network. Sci Rep. 2022;12(1):15600.
Google Scholar
Zhou Z, Chen L, Sher D, Zhang Q, Shah J, Pham N-L, Jiang S, Wang J. Predicting lymph node metastasis in head and neck cancer by combining Many-objective radiomics and 3-dimensioal convolutional neural network through evidential reasoning. Annu Int Conf IEEE Eng Med Biol Soc. 2018;2018:1–4.
Google Scholar
Li X, Zhang S, Zhang Q, Wei X, Pan Y, Zhao J, Xin X, Qin C, Wang X, Li J, et al. Diagnosis of thyroid cancer using deep convolutional neural network models applied to sonographic images: a retrospective, multicohort, diagnostic study. Lancet Oncol. 2019;20(2):193–201.
Google Scholar
Hammond MEH, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, et al. American society of clinical oncology/college of American pathologists guideline recommendations for immunohistochemical testing of Estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28(16):2784–95.
Google Scholar
Son J, Lee SE, Kim E-K, Kim S. Prediction of breast cancer molecular subtypes using radiomics signatures of synthetic mammography from digital breast tomosynthesis. Sci Rep. 2020;10(1):21566.
Google Scholar
Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thürlimann B, Senn HJ. Strategies for subtypes–dealing with the diversity of breast cancer: highlights of the st. Gallen international expert consensus on the primary therapy of early breast cancer 2011. Ann Oncol. 2011;22(8):1736–47.
Google Scholar
Zwanenburg A, Vallières M, Abdalah MA, Aerts HJWL, Andrearczyk V, Apte A, Ashrafinia S, Bakas S, Beukinga RJ, Boellaard R, et al. The image biomarker standardization initiative: standardized quantitative radiomics for High-Throughput image-based phenotyping. Radiology. 2020;295(2):328–38.
Google Scholar
He K, Zhang X, Ren S, Sun J. Deep residual learning for image recognition. In: Proceedings of the IEEE conference on computer vision and pattern recognition: 2016; 2016: 770–778.
Hu Y, Xie C, Yang H, Ho JWK, Wen J, Han L, Lam K-O, Wong IYH, Law SYK, Chiu KWH et al. Computed tomography-based deep-learning prediction of neoadjuvant chemoradiotherapy treatment response in esophageal squamous cell carcinoma. Radiother Oncol 2021, 154.
Jiang M, Li C-L, Luo X-M, Chuan Z-R, Lv W-Z, Li X, Cui X-W, Dietrich CF. Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer. Eur J Cancer 2021, 147.
Gao Y, Luo Y, Zhao C, Xiao M, Ma L, Li W, Qin J, Zhu Q, Jiang Y. Nomogram based on radiomics analysis of primary breast cancer ultrasound images: prediction of axillary lymph node tumor burden in patients. Eur Radiol. 2021;31(2):928–37.
Google Scholar
Lee SE, Han K, Kwak JY, Lee E, Kim E-K. Radiomics of US texture features in differential diagnosis between triple-negative breast cancer and fibroadenoma. Sci Rep. 2018;8(1):13546.
Google Scholar
Osapoetra LO, Chan W, Tran W, Kolios MC, Czarnota GJ. Comparison of methods for texture analysis of QUS parametric images in the characterization of breast lesions. PLoS ONE. 2020;15(12):e0244965.
Google Scholar
Osapoetra LO, Sannachi L, DiCenzo D, Quiaoit K, Fatima K, Czarnota GJ. Breast lesion characterization using quantitative ultrasound (QUS) and derivative texture methods. Transl Oncol. 2020;13(10):100827.
Google Scholar
Fan L, Strasser-Weippl K, Li J-J, St Louis J, Finkelstein DM, Yu K-D, Chen W-Q, Shao Z-M, Goss PE. Breast cancer in China. Lancet Oncol. 2014;15(7):e279–89.
Google Scholar
Zhu Q, Cronin EB, Currier AA, Vine HS, Huang M, Chen N, Xu C. Benign versus malignant breast masses: optical differentiation with US-guided optical imaging reconstruction. Radiology. 2005;237(1):57–66.
Google Scholar
Kratkiewicz K, Pattyn A, Alijabbari N, Mehrmohammadi M. Ultrasound and photoacoustic imaging of breast cancer: clinical systems, challenges, and future outlook. J Clin Med 2022, 11(5).
Zhu Q, Ricci A, Hegde P, Kane M, Cronin E, Merkulov A, Xu Y, Tavakoli B, Tannenbaum S. Assessment of functional differences in malignant and benign breast lesions and improvement of diagnostic accuracy by using US-guided diffuse optical tomography in conjunction with conventional US. Radiology. 2016;280(2):387–97.
Google Scholar
Park H-L, Hong J. Vacuum-assisted breast biopsy for breast cancer. Gland Surg. 2014;3(2):120–7.
Google Scholar
Wu J, Ge L, Jin Y, Wang Y, Hu L, Xu D, Wang Z. Development and validation of an ultrasound-based radiomics nomogram for predicting the luminal from non-luminal type in patients with breast carcinoma. Front Oncol. 2022;12:993466.
Google Scholar
Huang T, Fan B, Qiu Y, Zhang R, Wang X, Wang C, Lin H, Yan T, Dong W. Application of DCE-MRI radiomics signature analysis in differentiating molecular subtypes of luminal and non-luminal breast cancer. Front Med (Lausanne). 2023;10:1140514.
Google Scholar
Geitung J-T. Editorial for transfer learning strategy based on unsupervised learning and ensemble learning for breast cancer molecular subtype prediction using dynamic contrast enhanced MRI. J Magn Reson Imaging. 2022;55(5):1535.
Google Scholar
Wang M, Zhao L, Wei Y, Li J, Qi Z, Su N, Zhao C, Zhang R, Tang T, Liu S, et al. Functional photoacoustic/ultrasound imaging for the assessment of breast intraductal lesions: preliminary clinical findings. Biomed Opt Express. 2021;12(3):1236–46.
Google Scholar
Gu W, Chen Y, Zhu H, Chen H, Yang Z, Mo S, Zhao H, Chen L, Nakajima T, Yu X, et al. Development and validation of CT-based radiomics deep learning signatures to predict lymph node metastasis in non-functional pancreatic neuroendocrine tumors: a multicohort study. EClinicalMedicine. 2023;65:102269.
Google Scholar
Gu J, Tong T, He C, Xu M, Yang X, Tian J, Jiang T, Wang K. Deep learning radiomics of ultrasonography can predict response to neoadjuvant chemotherapy in breast cancer at an early stage of treatment: a prospective study. Eur Radiol. 2022;32(3):2099–109.
Google Scholar
Li C, Zhang H, Chen J, Shao S, Li X, Yao M, Zheng Y, Wu R, Shi J. Deep learning radiomics of ultrasonography for differentiating sclerosing adenosis from breast cancer. Clin Hemorheol Microcirc. 2023;84(2):153–63.
Google Scholar
